NCT05182203View on ClinicalTrials.gov

Safety and Retention Rate of the JAK and TNF Inhibitors in Rheumatoid Arthritis: a Real-life Experience

CompletedOBSERVATIONAL

Enrollment

1,732

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

September 1, 2022

Study Completion Date

October 1, 2022

Conditions

Rheumatoid ArthritisDrug Use

Interventions

DRUG

biologic/targeted therapy

TNF inhibitors or the JAK inhibitors

Trial Locations (1)

000

Department of Medicine, Tuen Mun Hospital, Hong Kong

All Listed Sponsors

lead

Tuen Mun Hospital

OTHER_GOV